Jürgen Finke

University of Freiburg — Germany

Medicine · Health Sciences

87h-index30.4kcitations877works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(409), Acute Myeloid Leukemia Research(302), Acute Lymphoblastic Leukemia research(192), Chronic Myeloid Leukemia Treatments(153), Lymphoma Diagnosis and Treatment(112)

Publications874 total

Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma – a retrospective multicentre clinical study
Haematologica·2025Open Access
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT
Bone Marrow Transplantation·2025
Low-Intensity Pretransplant Therapy in Acute Myeloid Leukemia: A 13-Year Single-Center Experience
2025Open Access
Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study
Bone Marrow Transplantation·2025· 1 citedOpen Access
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation
British Journal of Haematology·2025· 1 citedOpen Access
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated <i>versus</i> haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Haematologica·2025Open Access
Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
HemaSphere·2025· 2 citedOpen Access
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey
Bone Marrow Transplantation·2025· 3 citedOpen Access
Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid
Leukemia·2025· 1 citedOpen Access
Abstract PR009: Decitabine/venetoclax reduced-toxicity induction: a very effective bridge-to-transplant in older AML patients with non-favorable genetics
Cancer Research·2025
Neoplastische Erkrankungen
2025
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Bone Marrow Transplantation·2024· 1 citedOpen Access
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
Bone Marrow Transplantation·2024· 13 citedOpen Access
Guiding Treatment and Clinical Management of Patients with CNS Lymphomas By Minimal-Invasive Detection of Circulating Tumor DNA in Cerebrospinal Fluid
Blood·2024· 1 citedOpen Access
Machine Learning Based Prediction of One Year Mortality after Allogeneic Hematopoietic Cell Transplantation (alloHCT) Highlights Importance of Pre-Transplant Immunocompetence
Blood·2024Open Access
Combining Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in Relapsed or Refractory Central Nervous System Lymphoma - a Retrospective Clinical Study
Blood·2024Open Access
Changes in the Mutational Landscape in Acute Myeloid Leukemia Relapse Under Allogeneic Immune Pressure
Blood·2024Open Access
Guiding treatment and clinical management of patients with CNS lymphomas by minimal-invasive detection of circulating tumor DNA in cerebrospinal fluid
2024Open Access
Reduced Intensity Conditioning Prior Autologous Stem Cell Transplantation in Elderly <scp>DLBCL</scp> Patients
European Journal Of Haematology·2024Open Access
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens
Bone Marrow Transplantation·2024· 6 citedOpen Access
page 1 of 44Next →

Frequent Co-authors

Nicolaus Kröger(12), Dietger Niederwieser(10), Robert Zeiser(9), Gerald Illerhaus(8), Myriam Labopin(7), Jakob Passweg(7), Mohamad Mohty(7), Rainer Schwerdtfeger(6), Tapani Ruutu(6), Wolfgang Bethge(6), Liisa Volin(6), Ernst Holler(6), Martin Bornhäuser(6), Hartmut Bertz(6), Gèrard Socié(6), Martina Deckert(6), Stephan Stilgenbauer(6), Dietrich W. Beelen(6), Hans‐Jochem Kolb(5), Elisabeth Schorb(5)